Aspira Women’s Health Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Aspira Women’s Health Inc. (AWHL) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $25.79 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-01
- Aspira Women’s Health Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $25.79M, a 0.00% change from fiscal 2024.
- Aspira Women’s Health Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $25.79M.
- Aspira Women’s Health Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $2.00M, a 75.00% decline from fiscal 2017.
- Aspira Women’s Health Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $8.00M, a 81.40% decline from fiscal 2016.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $25.79M 10-K · filed 2026-04-01 |
| 2024-12-31 | $25.79M 10-K · filed 2026-04-01 |
| 2018-12-31 | $2.00M 10-K · filed 2019-03-28 |
| 2017-12-31 | $8.00M 10-K · filed 2018-03-13 |
| 2016-12-31 | $43.00M 10-K · filed 2017-03-31 |